首页> 外国专利> PREOPERATIVE METHOD FOR PREDICTING HEMOTRANSFUSION THERAPY TACTICS IN INTRA- AND POSTOPERATIVE PERIODS IN CARDIOSURGICAL CASES

PREOPERATIVE METHOD FOR PREDICTING HEMOTRANSFUSION THERAPY TACTICS IN INTRA- AND POSTOPERATIVE PERIODS IN CARDIOSURGICAL CASES

机译:术前预测心脏内外科手术中术中和术后的输血治疗策略的方法

摘要

FIELD: medicine.;SUBSTANCE: method involves determining blood parameters 1-2 days prior to operation on the general hypoxia test background and estimating tolerance to hypoxia. High tolerance to hypoxia being observed in intra- and postoperative period, hemotransfusion therapy is administered only on hemoglobin concentration dropping below 80 g/l, hemodilution being permitted to hematocrit value of 20% during artificial blood circulation; moderate tolerance to hypoxia being the case, hemotransfusion therapy is administered when hemoglobin concentration drops below 90 g/l, whereas hemodilution up to hematocrit value not lower than 25% is applicable in artificial blood circulation cases; low tolerance to hypoxia being the case, hemotransfusion therapy is applied, when hemoglobin concentration falls below 100 g/l, and hemodilution to hematocrit value not lower than 30% is administered at artificial blood circulation stage.;EFFECT: high accuracy in forecasting organism tolerance; improved cardiosurgical operation results; optimized hemotransfusion therapy; reduced risk of postoperative complications.
机译:领域:药物;方法:该方法涉及在一般的低氧测试背景下,在手术前1-2天确定血液参数,并评估其对低氧的耐受性。在术中和术后对低氧的耐受性很高,仅在血红蛋白浓度降至80 g / l以下时才进行输血治疗,在人工血液循环中允许血液稀释的血细胞比容值为20%。在低氧耐受性中等的情况下,当血红蛋白浓度降至90 g / l以下时进行输血治疗,而在人工血液循环病例中,血液稀释度应达到血细胞比容值不低于25%。缺氧耐受性低的情况下,当血红蛋白浓度低于100 g / l时采用输血疗法,在人工血液循环阶段进行血液稀释至血细胞比容值不低于30%。 ;改善心脏外科手术结果;优化的输血疗法;降低术后并发症的风险。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号